Updated 10 March 2026
Date of Inspection: 24 May 2026 to 29 May 2026. Naseby Medical Centre is a GP practice and delivers a service to 5,500 people under a contract held with NHS England. The National General Practice Profiles states that the practice population is 60% Asian, 21% White, 10% Black, 3% Mixed and 6% Other. Information published by Office for Health Improvement and Disparities shows that deprivation within the practice population group is in the 1st decile (1 of 10). The lower the decile, the more deprived the practice population is relative to others. This inspection considered the demographics of the people using the service, the context the service was working within and how this impacted service delivery. Where relevant, further commentary is provided in the quality statements section of this report.
On 7 August 2025 the Care Quality Commission (CQC) urgently suspended the registration of Naseby Medical Centre, in response to serious concerns identified during an inspection in July and August 2025. As a result of these concerns, we took urgent action to protect the safety and welfare of people using this service. Under Section 31 of the Health and Social Care Act 2008 we imposed a temporary suspension of 6 months on the registration of the provider in respect of the following activities: Diagnostic and screening procedures, Maternity and midwifery services and Treatment of disease, disorder or injury.
On 16 January 2026 we carried out a focused assessment to establish if the provider, Naseby Medical Centre, could resume the delivery of regulated activities. We identified that whilst the provider had made some progress towards rectifying the serious concerns the CQC had identified, they remained unable to demonstrate that effective governance arrangements would be implemented to manage risks, performance and delivery of safe care to patients who used the service. We found the provider did not have robust, comprehensive and effective plans in place to effectively and safely resume providing the regulated activities. As a result of this assessment CQC extended the temporary suspension of the provider’s registration for a further 3 months.
On 24 and 29 May 2026 we carried out a focused assessment to determine whether the 3-month suspension should be extended to continue protecting service users from identified risks of harm, or whether sufficient assurance had been provided to allow the suspension to be lifted. We found the provider did not have robust, comprehensive and effective plans in place to effectively and safely resume providing the regulated activities.
Leaders could not clearly describe how effective systems for managing long‑term conditions, medication reviews, high‑risk medicines, or accurate clinical record‑keeping would be implemented.
There was no assurance that the leadership team had developed the capability to embed a new workplace culture and practices and maintain it in the long-term. We remained concerned about the effectiveness of governance and risk management arrangements. There were insufficient improvements to demonstrate that identified patient safety risks had been adequately addressed. As a result of these ongoing significant risks, the suspension of registration was extended for a further 6 months until 7 November 2026.
This service was placed in special measures in August 2025. Insufficient improvements have been made such that there remains a rating of inadequate for Naseby Medical Centre. Therefore, we are taking urgent action in line with our enforcement procedures to prevent the provider from operating the service. The service will be kept under review and if needed could be escalated to further urgent enforcement action.